Stephen V Faraone Selected Research

Benzodiazepines

2/2015	Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study.
6/2014	Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.
2/2012	Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen V Faraone Research Topics

Disease

223	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2024 - 01/2002
30	Schizophrenia (Dementia Praecox) 01/2022 - 02/2002
16	Bipolar Disorder (Manic Depressive Psychosis) 02/2024 - 07/2002
13	Substance-Related Disorders (Drug Abuse) 01/2016 - 01/2003
10	Mania (Manias) 10/2022 - 05/2006
8	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 05/2004
5	Mood Disorders (Mood Disorder) 02/2024 - 01/2004
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 09/2012
4	Autism Spectrum Disorder 02/2024 - 06/2016
4	Antisocial Personality Disorder (Antisocial Personality) 01/2020 - 12/2007
4	Conduct Disorder (Conduct Disorders) 01/2019 - 02/2009
3	Genetic Risk Score 11/2023 - 01/2016
3	Hypertension (High Blood Pressure) 06/2023 - 01/2002
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2004
3	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 10/2007
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2019 - 07/2012
3	Autistic Disorder (Autism) 06/2016 - 01/2012
3	Anxiety Disorders (Anxiety Disorder) 02/2015 - 11/2009
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2014 - 03/2006
3	Tics (Tic) 01/2004 - 01/2002
2	Tic Disorders (Tic Disorder) 02/2024 - 07/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2023 - 03/2011
2	COVID-19 01/2023 - 12/2022
2	Neurodevelopmental Disorders 01/2022 - 01/2020
2	Sleep Wake Disorders 01/2021 - 01/2019
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 01/2019
2	Mental Disorders (Mental Disorder) 01/2021 - 04/2014
2	Epilepsy (Aura) 01/2021 - 07/2010
2	Oppositional Defiant Disorder 01/2019 - 02/2009
2	Hypersensitivity (Allergy) 01/2018 - 12/2014
2	Panic Disorder (Panic Attack) 12/2014 - 06/2005
2	Overweight 10/2013 - 09/2008

Drug/Important Bio-Agent (IBA)

40	Methylphenidate (Ritalin)FDA LinkGeneric 02/2024 - 06/2002
19	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2002
17	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 07/2004
16	Amphetamine (Amfetamine)FDA LinkGeneric 04/2024 - 04/2005
14	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2023 - 01/2002
13	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 01/2004
12	Lisdexamfetamine Dimesylate FDA Link 01/2021 - 06/2008
11	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2012
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2004
9	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2017 - 02/2005
8	ViloxazineIBA 04/2024 - 01/2021
8	Dopamine Receptors (Dopamine Receptor)IBA 01/2017 - 09/2003
7	SaltsIBA 01/2024 - 04/2005
7	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2005
7	3' Untranslated Regions (3' UTR)IBA 10/2013 - 04/2007
7	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2013 - 07/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2004
5	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 01/2022 - 05/2006
5	Nicotine FDA Link 01/2016 - 04/2002
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2013 - 01/2002
4	Guanfacine (Tenex)FDA LinkGeneric 01/2023 - 03/2010
4	AmphetaminesIBA 01/2018 - 03/2003
4	Indicators and Reagents (Reagents)IBA 01/2018 - 09/2002
4	Illicit Drugs (Recreational Drugs)IBA 01/2017 - 02/2006
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 07/2013 - 08/2005
4	SmokeIBA 09/2012 - 04/2002
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2009 - 05/2007
4	EnzymesIBA 06/2007 - 04/2003
4	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2007 - 03/2003
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 05/2004
3	Genetic Markers (Genetic Marker)IBA 11/2023 - 04/2008
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 10/2006
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2022 - 09/2012
3	Glutamic Acid (Glutamate)FDA Link 01/2019 - 01/2013
3	4-aminospiroperidolIBA 10/2018 - 12/2007
3	Naltrexone (ReVia)FDA LinkGeneric 03/2018 - 10/2014
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 09/2013
3	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2017 - 04/2014
3	BenzodiazepinesIBA 02/2015 - 02/2012
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2014 - 11/2008
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2013 - 12/2011
3	Bupropion (Wellbutrin)FDA LinkGeneric 01/2013 - 01/2002
3	Monoamine Oxidase (MAO)IBA 10/2012 - 06/2007
3	AdderallIBA 07/2007 - 06/2002
3	Serotonin ReceptorsIBA 07/2006 - 01/2006
3	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2006 - 03/2002
2	CreatinineIBA 06/2023 - 01/2018
2	Clonidine (ST 155)FDA LinkGeneric 01/2023 - 02/2015
2	ORALIT (ORS)IBA 10/2022 - 01/2021
2	Inositol (Myoinositol)IBA 10/2022 - 11/2015
2	Antimanic AgentsIBA 01/2022 - 08/2011
2	ApolipoproteinsIBA 01/2022 - 03/2010
2	Opioid Analgesics (Opioids)IBA 01/2020 - 10/2014
2	Cocaine (Cocaine HCl)IBA 01/2019 - 06/2006
2	Narcotic Antagonists (Opioid Antagonists)IBA 03/2018 - 01/2018
2	TOR Serine-Threonine KinasesIBA 01/2018 - 09/2012
2	Opiate AlkaloidsIBA 01/2018 - 06/2006
2	Memantine (Namenda)FDA Link 01/2017 - 06/2016
2	Protons (Proton)IBA 04/2016 - 08/2005
2	SodiumIBA 04/2016 - 10/2013
2	Messenger RNA (mRNA)IBA 01/2016 - 04/2005
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2016 - 10/2006
2	RNA (Ribonucleic Acid)IBA 10/2015 - 12/2008
2	alpha-2 Adrenergic ReceptorsIBA 11/2013 - 03/2006
2	Sodium-Hydrogen ExchangersIBA 10/2013 - 01/2012

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 01/2021 - 07/2002
17	Therapeutics 04/2024 - 07/2002
4	Aftercare (After-Treatment) 01/2019 - 10/2005